The Patient Capital Review may be of all-consuming interest to those who work in the tax-advantaged investment sector but, if you are only after a summary of the salient points, Jack Rose is happy to oblige
For those of us who work within the tax-advantaged investment sector, the impending outcome of the Patient Capital Review (PCR) - its possible permutations and consequences - is the talk of the town. ...
'FCA indicated it could penalise the firm'
The first rule of customer service
Sold property business
Warning of consumer credit bubble
12 financial planners on the panel